Fingerprint
Dive into the research topics of 'Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease
Maria Fleseriu, Rosario Pivonello, Jacques Young, Amir H. Hamrahian, Mark E. Molitch, Chikara Shimizu, Tomoaki Tanaka, Akira Shimatsu, Tracy White, Annie Hilliard, Chuan Tian, Nicholas Sauter, Beverly M.K. Biller, Xavier Bertagna
Research output: Contribution to journal › Article › peer-review
111
Scopus
citations